Skip to main content

Advertisement

Log in

Vitamin D supplementation for treatment and prevention of pneumonia in under-five children: A randomized double-blind placebo controlled trial

  • Research Paper
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To evaluate the efficacy of single oral mega-dose of Vitamin D3 for treatment and prevention of pneumonia in underfive children.

Design

Randomized, double blind, placebo-controlled trial.

Setting

Tertiary-care hospital.

Participants

324 children (of 980 assessed) between 6 mo-5 y age (median (IQR): 12 (7,19.8) mo) with WHO-defined severe pneumonia. Of these, 126 (39%) were vitamin D deficient (serum 25(OH)D <12 ng/mL).

Intervention

100,000 IU of oral cholecalciferol (n= 162) or placebo (n= 162) in single dose, administered at enrolment.

Outcome variables

Primary: Time to resolution of severe pneumonia and proportion of children having recurrence of pneumonia in next 6 months; Secondary: Change in serum levels of 25(OH)D; immunoglobulins IgA, IgG, IgM, and cathelicidin 2 weeks following supplementation; and time taken for overall resolution of illness.

Results

Median (95% CI) time for resolution of severe pneumonia was 30 (29, 31) h in the vitamin D group as compared to 31 (29,33) h in the placebo group [adjusted hazard ratio (95% CI): 1·39 (1·11, 1·76); P=0·005]. The risk of recurrence of pneumonia in next 6 months was comparable in the two groups [placebo: 36/158 (22·8%); vitamin D: 39/156 (25%); RR (95% CI): 1·13 (0·67,1·90); P=0·69]. Proportion of vitamin D deficient children declined from 38% to 4% in the supplementation group, and from 41% to 33% in the placebo group, two weeks after supplementation. There was no significant effect of vitamin D supplementation on serum levels of cathelicidin, IgA and IgG. The time taken for complete recovery from pneumonia, duration of hospitalization, and fever clearance time were comparable for the two groups. No adverse event was noted related to the intervention.

Conclusion

There is no robust evidence of a definite biological benefit, either for therapy or prevention, to suggest a routine megadose supplement of vitamin D3 for under-five children with severe pneumonia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. World Health Organization. Pneumonia fact sheet N 331. From http://www.who.int/mediacentre/factsheets/fs331/en. Accessed January 23, 2016.

  2. McNally JD, Leis K, Matheson LA, Karuananyake C, Sankaran K, Rosenberg AM. Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr Pulmonol. 2009;44:981–8.

    Article  PubMed  Google Scholar 

  3. Roth DE, Shah R, Black RE, Baqui AH. Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatr. 2010;99:389–93.

    Article  CAS  PubMed  Google Scholar 

  4. Karatekin G, Kaya A, Saliho Églu O, Balci H, NuhoÉglu A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2009;63:473–7.

    Article  CAS  PubMed  Google Scholar 

  5. Ahmed P, Babaniyi IB, Yusuf KK, Dodd C, Langdon G, Steinhoff M, Dawodu A. Vitamin D status and hospitalization for childhood acute lower respiratory tract infections in Nigeria. Paediatr Int Child Health. 2015; 35:151–6.

    Article  PubMed  Google Scholar 

  6. Shah N, Ramankutty V, Premila PG, Sathy N. Risk factors for severe pneumonia in children in south Kerala: a hospital-based case-control study. J Trop Pediatr. 1994;40:201–6.

    Article  CAS  PubMed  Google Scholar 

  7. Banajeh SM. Nutritional rickets and vitamin D deficiencyassociation with the outcomes of childhood very severe pneumonia: A prospective cohort study. Pediatr Pulmonol. 2009;44:1207–15.

    Article  PubMed  Google Scholar 

  8. Wayse V, Yousafzai A, Mogale K, Filteau S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur J Clin Nutr. 2004;58:563–7.

    Article  CAS  PubMed  Google Scholar 

  9. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–3.

    Article  CAS  PubMed  Google Scholar 

  10. Muhe L, Lulseged S, Mason KE, Simoes EAF. Case control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet. 1997;349:1801–4.

    Article  CAS  PubMed  Google Scholar 

  11. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91:1255–60.

    Article  CAS  PubMed  Google Scholar 

  12. Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol. 2011;127:1294–6.

    Article  PubMed  Google Scholar 

  13. Camargo CA Jr, Ganmaa D, Frazier AL, Kirchberg FF, Stuart JJ, Kleinman K, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012;130:e561–7.

    Article  PubMed  Google Scholar 

  14. Manaseki-Holland S, Qader G, Isaq Masher M, Bruce J, Zulf Mughal M, Chandramohan D, et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomized controlled trial. Trop Med Int Health. 2010;15:1148–55.

    Article  CAS  PubMed  Google Scholar 

  15. Manaseki-Holland S, Maroof Z, Bruce J, Mughal MZ, Masher MI, Bhutta ZA, et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomized controlled superiority trial. Lancet. 2012;379:1419–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Choudhary N, Gupta P. Vitamin D supplementation for severe pneumonia-a randomized controlled trial. Indian Pediatr. 2012;49:449–54.

    Article  PubMed  Google Scholar 

  17. Charan J, Goyal JP, Saxena D, Yadav P. Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis. J Pharmacol Pharmacother. 2012;3:300–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. World Health Organization. Technical bases for the WHO Recommendations on the Management of Pneumonia in Children at First level Health Care. Report no. WHO/ARI/91·20. Geneva: WHO; 1995.

  19. WHO Child and Adolescent Health and Development (CAH). Integrated management of neonatal and childhood illness and HIV. Physician Chart Booklet. New Delhi: Ministry of Health and Family Welfare, Govt. of India; 2007.

  20. World Health Organization. Physical status: The Use and Interpretation of Anthropometry. Report of WHO Expert Committee. Geneva: WHO; 1987.

  21. World Health Organization Anthro for personal computers, version 3·2·2, 2011: Software for assessing growth and development of the world’s children. Geneva: WHO; 2010. http://www.who.int/childgrowth/software/en/(accessed September 2011).

  22. World Health Organization, Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. Geneva: World Health Organization; 2006.

  23. Agarwal R, Singh V, Yewale V. RTI Facts. Indian Academy of Pediatrics Consensus Guidelines on Rational Management of Respiratory Tract Infections in Children. Mumbai: Indian Academy of Pediatrics; 2006.

    Google Scholar 

  24. Institute of Medicine Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press; 2011.

  25. Nicholson JF, Pesce MA. Reference ranges for laboratory tests and procedures. In: Behrman RE, Kliegman RM, editors. Nelson Textbook of Pediatrics. 17th edition. Philadelphia: Saunders; 2003 P 2396–427.

    Google Scholar 

  26. Hollick MF. The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep. 2006;4:96–102.

    Article  Google Scholar 

  27. Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells; presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983;57:1308–10.

    Article  CAS  PubMed  Google Scholar 

  28. Provvedini DM, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 promotes in vitro morphologic and enzymatic changes in normal human monocytes consistent with their differentiation into macrophages. Bone. 1986;7:23–8.

    Article  CAS  PubMed  Google Scholar 

  29. Pletz MW, Terkamp C, Schumacher U, Rohde G, Schütte H, Welte T, et al; CAPNETZ-Study Group. Vitamin D deficiency in community acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity. Respir Res. 2014;15:53.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Piyush Gupta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupta, P., Dewan, P., Shah, D. et al. Vitamin D supplementation for treatment and prevention of pneumonia in under-five children: A randomized double-blind placebo controlled trial . Indian Pediatr 53, 967–976 (2016). https://doi.org/10.1007/s13312-016-0970-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-016-0970-5

Keywords

Navigation